FIELD: medicine, oncology. SUBSTANCE: method involves additional administration of N-substituted benzamide to patient. This agent, for example, metoclopramide is able to activate adenosinediphosphate-ribosyltransferase. Proposed agent and method for suppression and/or abolishment of malignant tumor cells in human were used at chemio- or radiation therapy at enhanced cytotoxicity of these methods. EFFECT: enhanced effectiveness of method. 3 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR CANCER TREATMENT USING AUTOPHAGY INHIBITOR BASED ON THIOXANTHONE | 2011 |
|
RU2627588C2 |
| PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR ACTIVITY AND METHOD OF ITS PREPARING | 1994 |
|
RU2148401C1 |
| METHODS AND COMPOSITIONS FOR ACTIVATION MODULATION OF HEPATOCYTE GROWTH FACTOR | 2005 |
|
RU2405041C2 |
| ANGIOPOIETIC ANGIOPOIETIN-LIKE PROTEIN 4 INHIBITORS, IN COMBINATIONS AND APPLICATION | 2005 |
|
RU2392966C2 |
| METHODS OF TREATING CANCER DISEASES AND TUMORS USING PDE1 INHIBITORS | 2019 |
|
RU2811918C2 |
| NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING MALIGNANT GROWTH | 2011 |
|
RU2587619C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| COMBINED C-MET AND EGFR ANTAGONISTS THERAPY | 2009 |
|
RU2601892C2 |
| ANTIBODIES TO OX-2/CD200 AND THEIR APPLICATION | 2007 |
|
RU2520088C2 |
| COMPOSITION CONTAINING 1,2,4-BENZOTRIAZINE-3-AMINE-1,4-DIOXIDE FOR PARENTERAL ADMINISTRATION AND METHOD OF TREATMENT WITH ITS USE | 1996 |
|
RU2166946C2 |
